XRCC3 and cervical cancer: Pooled data revealed that XRCC3 RS861539 polymorphism was significantly associated with susceptibility to cervical cancer under the heterozygote genetic model (TC vs. CC: OR = 1.00, 95% CI 1.066-1.585, p = 0.009).